Joel Greenblatt fit · Magic Formula - high ROIC + cheap EV/EBIT
Is Sarepta Therapeutics,, Inc. Common Stock (SRPT) a Joel Greenblatt Stock?
Partial match — either cheap or high-quality, but not both.
41/100
DMixed signals
1/5 criteria passed
Joel Greenblatt's Criteria, Applied to SRPT
EBIT/EV yield ≥ 10%
key2.7%
ROIC ≥ 25%
key6.1%
EV/EBIT ≤ 12
37.2x
Gross margin ≥ 30%
76.3%
How SRPT Scores on Other Strategies
Live Financial Snapshot
Market cap
$1.77B
P/E (TTM)
31.3x
ROIC (TTM)
-1.53%
Gross margin
62.39%
Other Joel Greenblatt fit reports
Frequently Asked Questions
What is SRPT's Joel Greenblatt fit score?
SRPT scores 41/100 on our Joel Greenblatt fit engine — grade D. Partial match — either cheap or high-quality, but not both.
Does Joel Greenblatt actually own SRPT?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends SRPT.
How often is this score updated?
SRPT's Joel Greenblatt fit score is recomputed daily from the latest TTM financials.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Joel Greenblatt personally owns or recommends SRPT.